RAC 2.92% $1.94 race oncology ltd

Ann: Race 2022 AGM Presentations, page-34

  1. 2,658 Posts.
    lightbulb Created with Sketch. 2793
    I am interested in the Dox + AC combo for cardio protect. AC also appears to be very cardiotoxic so we are increasing toxicity.

    The preclinical must cover AC in the results otherwise it’s a bit of gamble so cardio-protect expanded. Interesting!
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.